Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.03
-0.21 (-2.27%)
At close: Apr 28, 2026, 4:00 PM EDT
9.19
+0.16 (1.77%)
After-hours: Apr 28, 2026, 5:00 PM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $534.76 million as of April 28, 2026. Its market cap has decreased by -23.41% in one year.
Market Cap
534.76M
Enterprise Value
1.74B
1-Year Change
-23.41%
Ranking
Category
Stock Price
$9.03
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $534.76M, a decrease of -80.02%. That is a compound annual growth rate of -32.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 547.19M | -22.21% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulse Biosciences | 1.54B |
| AtriCure | 1.47B |
| STAAR Surgical Company | 1.32B |
| Kestra Medical Technologies | 1.30B |
| Anbio Biotechnology | 1.21B |
| Azenta | 1.16B |
| BioLife Solutions | 1.03B |
| Anteris Technologies Global | 527.86M |